Tezepelumab safety check in Korea
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study watches how well tezepelumab (Tezspire) works in real life for people who are already taking it for approved reasons. It collects information to make sure the medicine is safe and effective outside of a clinical trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have received at least one dose of tezepelumab (Tezspire) as prescribed by your doctor.
- You agree to sign a consent form showing you understand the study.
- You are not taking tezepelumab for any condition outside its approved use.
- You are not currently in another research study testing a drug or treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if Tezepelumab improves lung and sinus barrier function in people with severe asthma. It includes those who also have chronic sinusitis with nasal polyps, to see if the drug helps both conditions.
This study tracks how well tezepelumab works for people with chronic sinusitis and nasal polyps in real-world settings. It aims to see if this medication reduces symptoms and the need for surgery.
This study follows patients with chronic rhinosinusitis with nasal polyps (CRSwNP)—a condition causing blocked sinuses and nasal growths—who are starting a new biologic medication called tezepelumab. Researchers will track how symptoms and quality of life improve over time in everyday medical practice.
This study tests a drug called tezepelumab for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve symptoms.
This trial tests if a drug called Tezepelumab can help adults with asthma who visit the emergency room. It aims to reduce severe asthma attacks and improve breathing control.
This trial tests if adding house dust mite allergy tablets (Acarizax) to tezepelumab (Tezspire) helps adults with severe allergic asthma stay in control. It is for people who are still struggling with asthma despite current treatments.
Hear when a new Severe Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.